See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Breaking into Precision Psychiatry

Summary by Inside Precision Medicine
There is a lot of potential for precision medicine to improve the diagnosis and treatment of psychiatric disorders like depression. The complexity of these conditions, a lack of reliable biomarkers, and various other factors have made targeted therapeutic development in this area hard, but this is something that Delphine Charvin, PhD, CEO and co-founder of Elkedonia, is hoping to change. The company was launched last year by French biotech incub…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Inside Precision MedicineInside Precision Medicine

Breaking into Precision Psychiatry

There is a lot of potential for precision medicine to improve the diagnosis and treatment of psychiatric disorders like depression. The complexity of these conditions, a lack of reliable biomarkers, and various other factors have made targeted therapeutic development in this area hard, but this is something that Delphine Charvin, PhD, CEO and co-founder of Elkedonia, is hoping to change. The company was launched last year by French biotech incub…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Inside Precision Medicine broke the news in on Friday, August 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Maryland icon

Maryland

News
For You
SearchBlindspotLocal